Skip to primary content

Skip to secondary content

Biotech 365

Search

Main menu

Biotech 365
Companies
Healthcare Investors
- Healthcare Investors Matchmaking
- Healthcare LPs
Preclinical Studies Database
- Scientific Due Diligence
- CRO & CDMO Database
Free DEMO
Services
Contact

Tag Archives: HIV-Therapeutics – HTI immunogen as therapeutic vaccine curing HIV infections

HIV-Therapeutics – HTI immunogen as therapeutic vaccine curing HIV infections

Posted on by

HIV-Therapeutics is developing a therapeutic vaccine against HIV infections and AIDS.

HIV-Therapeutics – HTI immunogen as therapeutic vaccine curing HIV infections

Continue reading →

Posted in Biotech Companies, Biotech Companies Spain | Tagged AIDS, beneficial epitope, beneficial epitopes, Christian Brander, HIV, HIV controller, HIV controllers, HIV gag protein, HIV infection, HIV infections, HIV nef protein, HIV pol protein, HIV vif protein, HIV-Therapeutic, HIV-Therapeutics, HIV-Therapeutics - HTI immunogen as therapeutic vaccine curing HIV infections, HIVACAT, HLA-restriction independent, HTI immunogen, Institute for AIDS Research, Institute for AIDS Research IrsiCaixa, IrsiCaixa, Jordi Naval, therapeutic vaccine

Search

Services Healthcare Investors Database FAQs CGU Biotech & Pharma News Contact

Proudly powered by WordPress